ArticleCancer drug resistance (Alhambra, Calif.)2018

Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomas.

Fatih M Uckun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.